M&A Deal Summary

Enzo Acquires BIOMOL International

On May 9, 2008, Enzo acquired medical products company BIOMOL International for 18M USD

Acquisition Highlights
  • This is Enzo’s 1st transaction in the Medical Products sector.
  • This is Enzo’s largest (disclosed) transaction.
  • This is Enzo’s 1st transaction in the United States.
  • This is Enzo’s 1st transaction in Pennsylvania.

M&A Deal Summary
Date 2008-05-09
Target BIOMOL International
Sector Medical Products
Buyer(s) Enzo
Deal Type Add-on Acquisition
Deal Value 18M USD

Target

BIOMOL International

Plymouth Meeting, Pennsylvania, United States
BIOMOL International, LP is a privately owned global producer of over 3,300 specialty life science products for the areas of signal transduction, lipid research, apoptosis, neuroscience and drug discovery, with a research focus in the field of functional proteomics.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Enzo

Farmingdale, New York, United States
Category Company
Founded 1976
Sector Life Science
Employees179
Revenue 31M USD (2023)
DESCRIPTION

Enzo is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community. Enzo was incorporated in 1976 and is based in Farmingdale, New York.

DEAL STATS #
Overall 1 of 2
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 2
State (Pennsylvania) 1 of 1
Country (United States) 1 of 2
Year (2008) 1 of 1
Size (of disclosed) 1 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-03-26 Assay Designs

Ann Arbor, Michigan, United States

Assay Designs, Inc. sells worldwide a steadily expanding research product line that includes kits and reagents for the detection and quantification of small molecules and proteins that are important in inflammation and immunity, oxidative and cellular stress, steroid and hormone biology, cell signaling, and bioenergetics.

Buy $12M
Mergr

Product

Company

Legal